Close
M Halloran

M. Elizabeth Halloran

Faculty Member

Education

Affiliations

Projects

Papers

Hladish TJ, Pearson CAB, Toh KB, Rojas DP, Manrique-Saide P, Vazquez-Prokopec GM, Halloran ME, Longini IM Jr.. (2020). Designing effective control of dengue with combined interventions. Proceedings of the National Academy of Sciences of the United States of America

Halloran ME, Longini IM, Gilbert PB. (2020). Designing a Study of Correlates of Risk for Ebola Vaccination. American journal of epidemiology

Gabriel EE, Sachs MC, Daniels MJ, Halloran ME. (2019). Optimizing and evaluating biomarker combinations as trial-level general surrogates. Statistics in medicine, 38(7)

Tsang TK, Ghebremariam SL, Gresh L, Gordon A, Halloran ME, Katzelnick LC, Rojas DP, Kuan G, Balmaseda A, Sugimoto J, Harris E, Longini IM Jr., Yang Y. (2019). Effects of infection history on dengue virus infection and pathogenicity. Nature communications, 10(1)

Matrajt L, Halloran ME, Antia R. (2019). Reply to Lindsey, Höschler and de Silva. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Potter GE, Wong J, Sugimoto J, Diallo A, Victor JC, Neuzil K, Halloran ME. (2019). Networks of face-to-face social contacts in Niakhar, Senegal. PLoS One, 14(8)

Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, Jasseh M, Nason M, Riveros X, Watson CH, Henao-Restrepo AM, Longini IM. (2019). Design of vaccine efficacy trials during public health emergencies. Science translational medicine, 11(499)

Basta NE, Halloran ME. (2019). Evaluating the Effectiveness of Vaccines Using a Regression Discontinuity Design. American journal of epidemiology, 188(6)

Halloran ME, Hudgens MG. (2018). Estimating population effects of vaccination using large, routinely collected data. Statistics in medicine, 37(2)

Sun K, Zhang Q, Pastore-Piontti A, Chinazzi M, Mistry D, Dean NE, Rojas DP, Merler S, Poletti P, Rossi L, Halloran ME, Longini IM Jr., Vespignani A. (2018). Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic. BMC medicine, 16(1)

Yang Y, Meng Y, Halloran ME, Longini IM Jr.. (2018). Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(2)

Tsang TK, Chen TM, Longini IM Jr., Halloran ME, Wu Y, Yang Y. (2018). Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in China. Epidemiology (Cambridge, Mass.), 29(5)

Yang Y, Meng Y, Halloran ME, Longini IM Jr.. (2018). Reply to Aguiar and Stollenwerk. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(4)

Hladish TJ, Pearson CAB, Patricia Rojas D, Gomez-Dantes H, Halloran ME, Vazquez-Prokopec GM, Longini IM. (2018). Forecasting the effectiveness of indoor residual spraying for reducing dengue burden. PLoS neglected tropical diseases, 12(6)

Gabriel EE, Sachs MC, Halloran ME. (2018). Evaluation and comparison of predictive individual-level general surrogates. Biostatistics (Oxford, England), 19(3)

Rojas DP, Barrera-Fuentes GA, Pavia-Ruz N, Salgado-Rodriguez M, Che-Mendoza A, Manrique-Saide P, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gomez-Dantes H. (2018). Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up. PLoS neglected tropical diseases, 12(11)

Dean NE, Halloran ME, Longini IM. (2018). Design of vaccine trials during outbreaks with and without a delayed vaccination comparator. The annals of applied statistics, 12(1)

Halloran ME, Hudgens MG. (2018). Comment on Laber et al. Journal of the Royal Statistical Society. Series C, Applied statistics, 67(4)

Zhang Q, Sun K, Chinazzi M, Pastore Y Piontti A, Dean NE, Rojas DP, Merler S, Mistry D, Poletti P, Rossi L, Bray M, Halloran ME, Longini IM Jr., Vespignani A. (2017). Spread of Zika virus in the Americas. Proceedings of the National Academy of Sciences of the United States of America, 114(22)

Halloran ME, Auranen K, Baird S, Basta NE, Bellan SE, Brookmeyer R, Cooper BS, DeGruttola V, Hughes JP, Lessler J, Lofgren ET, Longini IM, Onnela JP, Özler B, Seage GR, Smith TA, Vespignani A, Vynnycky E, Lipsitch M. (2017). Simulations for designing and interpreting intervention trials in infectious diseases. BMC medicine, 15(1)

Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E. (2017). Antibody-dependent enhancement of severe dengue disease in humans. Science (New York, N.Y.), 358(6365)

Dean NE, Halloran ME, Yang Y, Longini IM. (2016). Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62(10)

Zhou J, Chu H, Hudgens MG, Halloran ME. (2016). A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomes. Statistics in medicine, 35(1)

Rojas DP, Dean NE, Yang Y, Kenah E, Quintero J, Tomasi S, Ramirez EL, Kelly Y, Castro C, Carrasquilla G, Halloran ME, Longini IM. (2016). The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 21(28)

Ajelli M, Merler S, Fumanelli L, Pastore Y Piontti A, Dean NE, Longini IM Jr., Halloran ME, Vespignani A. (2016). Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis. BMC medicine, 14(1)

Hladish TJ, Pearson CA, Chao DL, Rojas DP, Recchia GL, Gómez-Dantés H, Halloran ME, Pulliam JR, Longini IM. (2016). Projected Impact of Dengue Vaccination in Yucatán, Mexico. PLoS neglected tropical diseases, 10(5)

Kenah E, Britton T, Halloran ME, Longini IM Jr.. (2016). Molecular Infectious Disease Epidemiology: Survival Analysis and Algorithms Linking Phylogenies to Transmission Trees. PLoS computational biology, 12(4)

Halloran ME, Hudgens MG. (2016). Dependent Happenings: A Recent Methodological Review. Current epidemiology reports, 3(4)

Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM Jr., Halloran ME, Vespignani A. (2016). Containing Ebola at the Source with Ring Vaccination. PLoS neglected tropical diseases, 10(11)

Gabriel EE, Daniels MJ, Halloran ME. (2016). Comparing biomarkers as trial level general surrogates. Biometrics, 72(4)

Schwartz LM, Halloran ME, Durbin AP, Longini IM Jr.. (2015). The dengue vaccine pipeline: Implications for the future of dengue control. Vaccine, 33(29)

Yang Y, Zhang Y, Fang L, Halloran ME, Ma M, Liang S, Kenah E, Britton T, Chen E, Hu J, Tang F, Cao W, Feng Z, Longini IM Jr.. (2015). Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 20(10)

Lipsitch M, Eyal N, Halloran ME, Hernán MA, Longini IM, Perencevich EN, Grais RF. (2015). Vaccine testing. Ebola and beyond. Science (New York, N.Y.), 348(6230)

Chao DL, Park JK, Marks F, Ochiai RL, Longini IM, Halloran ME. (2015). The contribution of neighbours to an individual's risk of typhoid outcome. Epidemiology and infection, 143(16)

Merler S, Ajelli M, Fumanelli L, Gomes MF, Piontti AP, Rossi L, Chao DL, Longini IM Jr., Halloran ME, Vespignani A. (2015). Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis. The Lancet. Infectious diseases, 15(2)

Matrajt L, Britton T, Halloran ME, Longini IM Jr.. (2015). One versus two doses: What is the best use of vaccine in an influenza pandemic?. Epidemics, (13)

Halloran ME, Vespignani A, Bharti N, Feldstein LR, Alexander KA, Ferrari M, Shaman J, Drake JM, Porco T, Eisenberg JN, Del Valle SY, Lofgren E, Scarpino SV, Eisenberg MC, Gao D, Hyman JM, Eubank S, Longini IM Jr.. (2014). Ebola: mobility data. Science (New York, N.Y.), 346(6208)

Lofgren ET, Halloran ME, Rivers CM, Drake JM, Porco TC, Lewis B, Yang W, Vespignani A, Shaman J, Eisenberg JN, Eisenberg MC, Marathe M, Scarpino SV, Alexander KA, Meza R, Ferrari MJ, Hyman JM, Meyers LA, Eubank S. (2014). Opinion: Mathematical models: a key tool for outbreak response. Proceedings of the National Academy of Sciences of the United States of America, 111(51)

Halloran ME, Longini IM Jr.. (2014). Emerging, evolving, and established infectious diseases and interventions. Science (New York, N.Y.), 345(6202)

Gomes MF, Pastore Y Piontti A, Rossi L, Chao D, Longini I, Halloran ME, Vespignani A. (2014). Assessing the international spreading risk associated with the 2014 west african ebola outbreak. PLoS currents, (6)

VanderWeele TJ, Tchetgen Tchetgen EJ, Halloran ME. (2014). Interference and Sensitivity Analysis. Statistical science : a review journal of the Institute of Mathematical Statistics, 29(4)

Sugimoto JD, Koepke AA, Kenah EE, Halloran ME, Chowdhury F, Khan AI, LaRocque RC, Yang Y, Ryan ET, Qadri F, Calderwood SB, Harris JB, Longini IM Jr.. (2014). Household Transmission of Vibrio cholerae in Bangladesh. PLoS neglected tropical diseases, 8(11)

Yang Y, Halloran ME, Chen Y, Kenah E. (2014). A pathway EM-algorithm for estimating vaccine efficacy with a non-monotone validation set. Biometrics, 70(3)

Chao DL, Longini IM Jr., Halloran ME. (2013). The effects of vector movement and distribution in a mathematical model of dengue transmission. PLoS One, 8(10)

Matrajt L, Halloran ME, Longini IM Jr.. (2013). Optimal vaccine allocation for the early mitigation of pandemic influenza. PLoS computational biology, 9(3)

Auranen K, Rinta-Kokko H, Halloran ME. (2013). Estimating strain-specific and overall efficacy of polyvalent vaccines against recurrent pathogens from a cross-sectional study. Biometrics, 69(1)

Chao DL, Halstead SB, Halloran ME, Longini IM Jr.. (2012). Controlling dengue with vaccines in Thailand. PLoS neglected tropical diseases, 6(10)

Halloran ME, Hudgens MG. (2012). Causal inference for vaccine effects on infectiousness. The international journal of biostatistics, 8(2)

Halloran ME. (2012). The Minicommunity Design to Assess Indirect Effects of Vaccination. Epidemiologic methods, 1(1)

Potter GE, Handcock MS, Longini IM Jr., Halloran ME. (2012). ESTIMATING WITHIN-SCHOOL CONTACT NETWORKS TO UNDERSTAND INFLUENZA TRANSMISSION. The annals of applied statistics, 6(1)

Vanderweele TJ, Tchetgen Tchetgen EJ, Halloran ME. (2012). Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects. Epidemiology (Cambridge, Mass.), 23(5)

Halloran ME, Hudgens MG. (2012). Comparing bounds for vaccine effects on infectiousness. Epidemiology (Cambridge, Mass.), 23(6)

Yang Y, Longini IM Jr., Halloran ME, Obenchain V. (2012). A hybrid EM and Monte Carlo EM algorithm and its application to analysis of transmission of infectious diseases. Biometrics, 68(4)

Chao DL, Halloran ME, Longini IM Jr.. (2011). Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proceedings of the National Academy of Sciences of the United States of America, 108(17)

Chao DL, Matrajt L, Basta NE, Sugimoto JD, Dean B, Bagwell DA, Oiulfstad B, Halloran ME, Longini IM Jr.. (2011). Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States. American journal of epidemiology, 173(10)

Kenah E, Chao DL, Matrajt L, Halloran ME, Longini IM Jr.. (2011). The global transmission and control of influenza. PLoS One, 6(5)

Potter GE, Handcock MS, Longini IM Jr., Halloran ME. (2011). ESTIMATING WITHIN-HOUSEHOLD CONTACT NETWORKS FROM EGOCENTRIC DATA. The annals of applied statistics, 5(3)

Chao DL, Halloran ME, Obenchain VJ, Longini IM Jr.. (2010). FluTE, a publicly available stochastic influenza epidemic simulation model. PLoS computational biology, 6(1)

Chao DL, Halloran ME, Longini IM Jr.. (2010). School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States. The Journal of infectious diseases, 202(6)

Yang Y, Halloran ME, Daniels MJ, Longini IM Jr., Burke DS, Cummings DA. (2010). Modeling Competing Infectious Pathogens from a Bayesian Perspective: Application to Influenza Studies with Incomplete Laboratory Results. Journal of the American Statistical Association, 105(492)

Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM Jr.. (2009). The transmissibility and control of pandemic influenza A (H1N1) virus. Science (New York, N.Y.), 326(5953)

Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM Jr., Dye C, Halloran ME. (2009). Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proceedings of the National Academy of Sciences of the United States of America, 106(33)

Basta NE, Chao DL, Halloran ME, Matrajt L, Longini IM Jr.. (2009). Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. American journal of epidemiology, 170(6)

Halloran ME, Holmes EC. (2009). Invited commentary: Evaluating vaccination programs using genetic sequence data. American journal of epidemiology, 170(12)

Halloran ME. (2009). On influenza and school closings: time for prospective studies. Epidemiology (Cambridge, Mass.), 20(6)

Yang Y, Halloran ME, Longini IM Jr.. (2009). A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections. Biostatistics (Oxford, England), 10(2)

Sander B, Nizam A, Garrison LP Jr., Postma MJ, Halloran ME, Longini IM Jr.. (2008). Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 12(2)

Halloran ME, Ferguson NM, Eubank S, Longini IM Jr., Cummings DA, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC, Wagener D, Beckman R, Kadau K, Barrett C, Macken CA, Burke DS, Cooley P. (2008). Modeling targeted layered containment of an influenza pandemic in the United States. Proceedings of the National Academy of Sciences of the United States of America, 105(12)

Basta NE, Halloran ME, Matrajt L, Longini IM Jr.. (2008). Estimating influenza vaccine efficacy from challenge and community-based study data. American journal of epidemiology, 168(12)

Hudgens MG, Halloran ME. (2008). Toward Causal Inference With Interference. Journal of the American Statistical Association, 103(482)

Yang Y, Gilbert P, Longini IM, Halloran ME. (2008). A Bayesian Framework for Estimating Vaccine Efficacy per Infectious Contact. The annals of applied statistics, 2(4)

Halloran ME, Piedra PA, Longini IM Jr., Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP. (2007). Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine, 25(20)

Halloran ME, Hayden FG, Yang Y, Longini IM Jr., Monto AS. (2007). Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. American journal of epidemiology, 165(2)

Yang Y, Longini IM, Halloran ME. (2007). A Data-Augmentation Method for Infectious Disease Incidence Data from Close Contact Groups. Computational statistics & data analysis, 51(12)

Struchiner CJ, Halloran ME. (2007). Randomization and baseline transmission in vaccine field trials. Epidemiology and infection, 135(2)

Yang Y, Halloran ME, Sugimoto JD, Longini IM Jr.. (2007). Detecting human-to-human transmission of avian influenza A (H5N1). Emerging infectious diseases, 13(9)

Longini IM Jr., Halloran ME, Nizam A, Yang Y, Xu S, Burke DS, Cummings DA, Epstein JM. (2007). Containing a large bioterrorist smallpox attack: a computer simulation approach. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 11(2)

Yang Y, Longini IM, Halloran ME. (2007). A Resampling-Based Test to Detect Person-To-Person Transmission of Infectious Disease. The annals of applied statistics, 1(1)

Halloran ME. (2006). Invited commentary: Challenges of using contact data to understand acute respiratory disease transmission. American journal of epidemiology, 164(10)

Halloran ME, Longini IM Jr.. (2006). Public health. Community studies for vaccinating schoolchildren against influenza. Science (New York, N.Y.), 311(5761)

Halloran ME. (2006). Overview of vaccine field studies: types of effects and designs. Journal of biopharmaceutical statistics, 16(4)

Yang Y, Longini IM Jr., Halloran ME. (2006). Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact Groups. Journal of the Royal Statistical Society. Series C, Applied statistics, 55(3)

Hudgens MG, Halloran ME. (2006). Causal Vaccine Effects on Binary Postinfection Outcomes. Journal of the American Statistical Association, 101(473)

Patel R, Longini IM Jr., Halloran ME. (2005). Finding optimal vaccination strategies for pandemic influenza using genetic algorithms. Journal of theoretical biology, 234(2)

Longini IM Jr., Halloran ME. (2005). Strategy for distribution of influenza vaccine to high-risk groups and children. American journal of epidemiology, 161(4)

Longini IM Jr., Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, Halloran ME. (2005). Containing pandemic influenza at the source. Science (New York, N.Y.), 309(5737)

Chu H, Halloran ME. (2004). Estimating vaccine efficacy using auxiliary outcome data and a small validation sample. Statistics in medicine, 23(17)

Chu H, Préziosi MP, Halloran ME. (2004). Estimating heterogeneous transmission with multiple infectives using MCMC methods. Statistics in medicine, 23(1)

Glezen WP, Piedra PA, Longini IM, Halloran ME. (2004). Safety of cold-adapted live influenza vaccine. The Pediatric infectious disease journal, 23(6)

Longini IM Jr., Halloran ME, Nizam A, Yang Y. (2004). Containing pandemic influenza with antiviral agents. American journal of epidemiology, 159(7)

Chu H, Halloran ME. (2004). Bayesian estimation of vaccine efficacy. Clinical trials (London, England), 1(3)

Préziosi MP, Halloran ME. (2003). Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine, 21(17-18)

Halloran ME, Longini IM Jr., Gaglani MJ, Piedra PA, Chu H, Herschler GB, Glezen WP. (2003). Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. American journal of epidemiology, 158(4)

Préziosi MP, Halloran ME. (2003). Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37(6)

Longini IM Jr., Halloran ME, Nizam A. (2002). Model-based estimation of vaccine effects from community vaccine trials. Statistics in medicine, 21(4)

Halloran ME, Longini IM Jr., Nizam A, Yang Y. (2002). Containing bioterrorist smallpox. Science (New York, N.Y.), 298(5597)

Halloran ME, Longini IM, Cowart DM, Nizam A. (2002). Community interventions and the epidemic prevention potential. Vaccine, 20(27-28)

Halloran ME, Longini IM Jr.. (2001). Using validation sets for outcomes and exposure to infection in vaccine field studies. American journal of epidemiology, 154(5)

Halloran ME, Longini IM Jr., Struchiner CJ. (1999). Design and interpretation of vaccine field studies. Epidemiologic reviews, 21(1)

Longini IM Jr., Sagatelian K, Rida WN, Halloran ME. (1998). Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. Statistics in medicine, 17(10)

Stephens DS, Levin B, Halloran ME. (1998). Symposium on population biology, evolution, and control of infectious diseases. Introduction. The American journal of the medical sciences, 315(2)

Halloran ME, Anderson RM, Azevedo-Neto RS, Bellini WJ, Branch O, Burke MA, Compans R, Day K, Gooding L, Gupta S, Katz J, Kew O, Keyserling H, Krause R, Lal AA, Massad E, McLean AR, Rosa P, Rota P, Wiener P, Wynn SG, Zanetta DM. (1998). Population biology, evolution, and immunology of vaccination and vaccination programs. The American journal of the medical sciences, 315(2)

Halloran ME, Struchiner CJ, Longini IM Jr.. (1997). Study designs for evaluating different efficacy and effectiveness aspects of vaccines. American journal of epidemiology, 146(10)

Bertolli J, Pangi C, Frerichs R, Halloran ME. (1997). A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar. International journal of epidemiology, 26(4)

Mosure DJ, Berman S, Kleinbaum D, Halloran ME. (1996). Predictors of Chlamydia trachomatis infection among female adolescents: a longitudinal analysis. American journal of epidemiology, 144(10)

Longini IM Jr., Datta S, Halloran ME. (1996). Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 13(5)

Antia R, Halloran ME. (1996). Recent developments in theories of pathogenesis of AIDS. Trends in microbiology, 4(7)

Halloran ME, Longini IM Jr., Struchiner CJ. (1996). Estimability and interpretation of vaccine efficacy using frailty mixing models. American journal of epidemiology, 144(1)

Halloran ME. (1996). Epidemiologic effects of varicella vaccination. Infectious disease clinics of North America, 10(3)

Longini IM Jr., Halloran ME. (1995). AIDS: modeling epidemic control. Science (New York, N.Y.), 267(5202)

Haber M, Watelet L, Halloran ME. (1995). On individual and population effectiveness of vaccination. International journal of epidemiology, 24(6)

Halloran ME, Struchiner CJ. (1995). Causal inference in infectious diseases. Epidemiology (Cambridge, Mass.), 6(2)

Noronha CP, Struchiner CJ, Halloran ME. (1995). Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. International journal of epidemiology, 24(5)

Halloran ME, Longini IM Jr., Haber MJ, Struchiner CJ, Brunet RC. (1994). Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field. Statistics in medicine, 13(4)

Halloran ME, Cochi SL, Lieu TA, Wharton M, Fehrs L. (1994). Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. American journal of epidemiology, 140(2)

Halloran ME. (1994). Mycobacterium tuberculosis: just desserts for an ungrateful guest. Trends in ecology & evolution, 9(2)

Halloran ME, Watelet L, Struchiner CJ. (1994). Epidemiologic effects of vaccines with complex direct effects in an age-structured population. Mathematical biosciences, 121(2)

Devine OJ, Louis TA, Halloran ME. (1994). Empirical Bayes methods for stabilizing incidence rates before mapping. Epidemiology (Cambridge, Mass.), 5(6)

Halloran ME. (1993). Salmonella enteritidis infections in France and the United States: causes vs causal models. American journal of public health, 83(12)

Brunet RC, Struchiner CJ, Halloran ME. (1993). On the distribution of vaccine protection under heterogeneous response. Mathematical biosciences, 116(1)

Schapira A, Beales PF, Halloran ME. (1993). Malaria: living with drug resistance. Parasitology today (Personal ed.), 9(5)

Halloran ME. (1992). Persistence, drugs and rock'n'roll. Trends in ecology & evolution, 7(7)

Halloran ME, Struchiner CJ. (1992). Modeling transmission dynamics of stage-specific malaria vaccines. Parasitology today (Personal ed.), 8(3)

Struchiner CJ, Halloran ME. (1992). Modeling AIDS vaccines: the cellular level. Memorias do Instituto Oswaldo Cruz, 87(1)

Halloran ME, Haber M, Longini IM Jr.. (1992). Interpretation and estimation of vaccine efficacy under heterogeneity. American journal of epidemiology, 136(3)

Halloran ME, Haber M, Longini IM Jr., Struchiner CJ. (1991). Direct and indirect effects in vaccine efficacy and effectiveness. American journal of epidemiology, 133(4)

Halloran ME, Struchiner CJ. (1991). Study designs for dependent happenings. Epidemiology (Cambridge, Mass.), 2(5)

Haber M, Longini IM Jr., Halloran ME. (1991). Measures of the effects of vaccination in a randomly mixing population. International journal of epidemiology, 20(1)

Haber M, Longini IM Jr., Halloran ME. (1991). Estimation of vaccine efficacy in outbreaks of acute infectious diseases. Statistics in medicine, 10(10)

Longini IM Jr., Haber MJ, Halloran ME. (1990). [Direct and indirect effects of vaccines: an annotation on the estimation of the vaccine efficacy from outbreaks caused by acute infection agents such as measles]. Boletin medico del Hospital Infantil de Mexico, 47(7)

Halloran ME, Struchiner CJ, Spielman A. (1989). Modeling malaria vaccines. II: Population effects of stage-specific malaria vaccines dependent on natural boosting. Mathematical biosciences, 94(1)

Halloran ME, Bundy DA, Pollitt E. (1989). Infectious disease and the Unesco basic education initiative. Parasitology today (Personal ed.), 5(11)